Collin Imhof

Collin Imhof is an experienced executive specializing in transfer pricing and tax controversy, currently serving as Executive Director of Transfer Pricing at Organon since January 2021. Prior to this role, Imhof held the same position at Merck for a brief period and served as Senior Director of Transfer Pricing & Tax Controversy at both Bristol-Myers Squibb and Celgene. Imhof began the professional career at PwC, attaining the role of Transfer Pricing Controversy Manager and later working as a Transfer Pricing Intern. Academic credentials include a Doctor of Law (JD) from William & Mary Law School and a Bachelor's degree in Economics from the Schreyer Honors College at Penn State.